DB06661Experimental
GMK vaccine (a ganglioside conjugate vaccine coupled to keyhole limpet hemocyanin and formulated with the adjuvant QS-21) for the potential treatment of melanoma.
- Mechanism
- Curator reviewed
Pharmacologically active on Acetylcholinesterase and Protein Wnt-3a
- Primary indication
- Investigated for use/treatment in melanoma.Curator reviewed
- Also known as
- GMK vaccine
Resolves to
Targets
What you can answer from here — as of July 19, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with GMK, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account